NDC-11 (Package) | NDC-9 (Product) | Generic Name (Descending) | Brand Name | Strength | SEER*Rx Category | Major Class | Minor Class | Administration Route | Package Effective Date | Package Discontinuation Date | Status |
---|---|---|---|---|---|---|---|---|---|---|---|
00078-1098-30 | 00078-1098 | asciminib | SCEMBLIX | 40.0 mg/1 | Chemotherapy | Tyrosine Kinase Inhibitor | ABL/BCR-ABL1 | Oral | Oct. 29, 2021 | In Use | |
00078-1098-94 | 00078-1098 | asciminib | SCEMBLIX | 40.0 mg/1 | Chemotherapy | Tyrosine Kinase Inhibitor | ABL/BCR-ABL1 | Oral | Oct. 29, 2021 | In Use | |
50742-0525-07 | 50742-0525 | arsenic trioxide | ARSENIC TRIOXIDE | 2.0 mg/mL | Chemotherapy | Miscellaneous Agent | PML/RARa | Intravenous | Jan. 27, 2021 | In Use | |
50742-0438-10 | 50742-0438 | arsenic trioxide | ARSENIC TRIOXIDE | 1.0 mg/mL | Chemotherapy | Miscellaneous Agent | PML/RARa | Intravenous | Nov. 15, 2018 | In Use | |
47426-0201-01 | 47426-0201 | aprepitant | CINVANTI | 130.0 mg/18mL | Ancillary Therapy | Antiemetic | Substance P/Neurokinin 1 | Intravenous | Jan. 3, 2018 | In Use | |
59212-0601-22 | 59212-0601 | alitretinoin | PANRETIN | 60.0 mg/60g | Hormonal Therapy | Immunomodulator | Retinoic Acid Derivative | Topical | Sept. 10, 2019 | In Use | |
47335-0401-81 | 47335-0401 | abiraterone acetate | YONSA | 125.0 mg/1 | Hormonal Therapy | Androgen Receptor Inhibitor | CYP17 Inhibitor | Oral | May 22, 2018 | In Use | |
00378-6921-91 | 00378-6921 | abiraterone acetate | Abiraterone Acetate | 500.0 mg/1 | Hormonal Therapy | Androgen Receptor Inhibitor | CYP17 Inhibitor | Oral | Dec. 14, 2020 | In Use | |
67457-0920-05 | 67457-0920 | Zoledronic acid | Zoledronic acid | 4.0 mg/5mL | Ancillary Therapy | Bisphosphonate | Intravenous | Oct. 12, 2020 | May 31, 2021 | In Use | |
72603-0198-01 | 72603-0198 | Zoledronic acid | Zoledronic acid | 4.0 mg/5mL | Ancillary Therapy | Bisphosphonate | Intravenous | Nov. 1, 2023 | In Use | ||
68083-0615-01 | 68083-0615 | Zoledronic acid | Zoledronic Acid | 4.0 mg/5mL | Ancillary Therapy | Bisphosphonate | Intravenous | Nov. 8, 2023 | In Use | ||
68001-0610-25 | 68001-0610 | Zoledronic acid | Zoledronic acid | 4.0 mg/5mL | Ancillary Therapy | Bisphosphonate | Intravenous | Feb. 28, 2024 | In Use | ||
43598-0255-52 | 43598-0255 | Zoledronic acid | Zoledronic acid | 4.0 mg/100mL | Ancillary Therapy | Bisphosphonate | Intravenous | Jan. 15, 2019 | In Use | ||
68001-0437-25 | 68001-0437 | Zoledronic acid | Zoledronic acid | 4.0 mg/5mL | Ancillary Therapy | Bisphosphonate | Intravenous | June 29, 2020 | In Use | ||
67457-0390-54 | 67457-0390 | Zoledronic Acid | Zoledronic Acid | 4.0 mg/5mL | Ancillary Therapy | Bisphosphonate | Intravenous | March 10, 2014 | In Use | ||
00078-0387-25 | 00078-0387 | Zoledronic Acid | Zometa | 4.0 mg/5mL | Ancillary Therapy | Bisphosphonate | Intravenous | Aug. 20, 2001 | Nov. 30, 2020 | No Longer Used | |
00078-0590-61 | 00078-0590 | Zoledronic Acid | Zometa | 4.0 mg/100mL | Ancillary Therapy | Bisphosphonate | Intravenous | Aug. 20, 2001 | Jan. 31, 2020 | No Longer Used | |
00409-4229-01 | 00409-4229 | Zoledronic Acid | Zoledronic Acid | 4.0 mg/100mL | Ancillary Therapy | Bisphosphonate | Intravenous | Oct. 19, 2017 | July 30, 2021 | In Use | |
42023-0151-01 | 42023-0151 | Zoledronic Acid | Zoledronic Acid | 4.0 mg/5mL | Ancillary Therapy | Bisphosphonate | Intravenous | March 4, 2013 | Feb. 25, 2020 | In Use | |
45963-0440-55 | 45963-0440 | Zoledronic Acid | Zoledronic Acid | 4.0 mg/5mL | Ancillary Therapy | Bisphosphonate | Intravenous | April 13, 2015 | May 31, 2019 | No Longer Used | |
53150-0871-01 | 53150-0871 | Zoledronic Acid | Zoledronic Acid | 4.0 mg/5mL | Ancillary Therapy | Bisphosphonate | Intravenous | April 23, 2012 | Dec. 31, 2017 | No Longer Used | |
63323-0961-98 | 63323-0961 | Zoledronic Acid | Zoledronic Acid | 4.0 mg/5mL | Ancillary Therapy | Bisphosphonate | Intravenous | Sept. 4, 2014 | In Use | ||
51991-0065-97 | 51991-0065 | Zoledronic Acid | Zoledronic Acid | 4.0 mg/5mL | Ancillary Therapy | Bisphosphonate | Intravenous | May 1, 2020 | May 2, 2020 | No Longer Used | |
51991-0065-98 | 51991-0065 | Zoledronic Acid | Zoledronic Acid | 4.0 mg/5mL | Ancillary Therapy | Bisphosphonate | Intravenous | Sept. 15, 2017 | May 31, 2022 | No Longer Used | |
68001-0366-25 | 68001-0366 | Zoledronic Acid | Zoledronic Acid | 4.0 mg/5mL | Ancillary Therapy | Bisphosphonate | Intravenous | Oct. 5, 2018 | May 31, 2022 | No Longer Used |
Found 10,000 results in 3 milliseconds — Export these results